Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis.
liver disease
microbiome
nutrition
pancreas
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
04
07
2021
received:
03
06
2021
accepted:
07
07
2021
pubmed:
27
7
2021
medline:
15
12
2021
entrez:
26
7
2021
Statut:
ppublish
Résumé
The multisystemic manifestations of cystic fibrosis (CF) involve all parts of the gastrointestinal (GI) system, including the pancreas, intestine, and liver. As providers who care for people with CF, knowledge of the manifestations, treatment, and research related to nutrition and GI disease are important. This review is the last installment of the CF year in review 2020 series, focusing on nutritional, GI, and hepatobiliary articles from Pediatric Pulmonology and other journals of particular interest to clinicians.
Substances chimiques
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3120-3125Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Poli P, Conforti C, Gennari E, Padoan R. Transitory pancreatic insufficiency in cystic fibrosis children. J Cyst Fibros. 2020;19(1):e5-e6.
Boon M, Calvo-Lerma J, Claes I, et al. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with cystic fibrosis. J Cyst Fibros. 2020;19(4):562-568.
Calvo-Lerma J, Boon M, Colombo C, et al. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis. J Cyst Fibros. 2020.
Viola G, Mietto L, Secchi F, Ping L, Bruni A. Absorption and distribution of arachidonate in rats receiving lysophospholipids by oral route. J Lipid Res. 1993;34(11):1843-1852.
Stallings VA, Tindall AM, Mascarenhas MR, Maqbool A, Schall JI. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: a randomized controlled trial. PLoS One. 2020;15(5):1-13.
Tham A, Katz TE, Sutherland RE, et al. Micronutrient intake in children with cystic fibrosis in Sydney, Australia. J Cyst Fibros. 2020;19(1):146-152.
Harindhanavudhi T, Wang Q, Dunitz J, Moran A, Moheet A. Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: a single-center analysis. J Cyst Fibros. 2020;19(1):139-145.
Lahiri T, Sullivan JS, Sartorelli KH, Murphy JJ. Delayed presentation of meconium ileus in an infant with cystic fibrosis. Pediatrics. 2020;146(4):e20193717.
Christensen C, Sivapatham G, McKinney ML, Stammers D. Sulfhemoglobinemia associated with meconium ileus in cystic fibrosis. Pediatr Pulmonol. 2020;55(10):2496-2497.
Morales Morales CA, Gonzalez-Urquijo M, Morales Flores LF, et al. Proximal intestinal obstruction syndrome (PIOS) in a patient with cystic fibrosis: a case report. Ann Med Surg. 2020;60:669-672.
Klouda TM, Lindholm E, Poletto E, Rani S, Varlotta L, Velasco J. Presentation of an H-type tracheoesophageal fistula in an adolescent male with cystic fibrosis: a case report and review of literature. Clin Imaging. 2020;60(1):38-47.
Kuczynski J, Liu Z, Lozupone C, Mcdonald D, Fierer N, Knight R. Microbial community resemblance methods differ in their ability to detect biologically relevant patterns. Nat Methods. 2010;7(10):813-819.
Lozupone CA, Knight R. Species divergence and the measurement of microbial diversity. FEMS Microbiol Rev. 2008;32(4):557-578.
Kristensen M, Prevaes SMPJ, Kalkman G, et al. Development of the gut microbiota in early life: the impact of cystic fibrosis and antibiotic treatment. J Cyst Fibros. 2020;19(4):553-561.
Khalaf RT, Furura GT, Wagner BD, et al. Influence of acid blockade on the aerodigestive tract microbiome in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2021;72(4):520-527.
Loman BR, Shrestha CL, Thompson R, et al. Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis. Pediatr Pulmonol. 2020;55(7):1661-1670.
Hayden HS, Eng A, Pope CE, et al. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure. Nat Med. 2020;26(2):215-221.
Coffey MJ, Low I, Stelzer-Braid S, et al. The intestinal virome in children with cystic fibrosis differs from healthy controls. PLoS One. 2020;15(5):e0233557.
Beaufils F, Mas E, Mittaine M, et al. Increased fecal calprotectin is associated with worse gastrointestinal symptoms and quality of life scores in children with cystic fibrosis. J Clin Med. 2020;9(12):4080.
Siegel MJ, Freeman AJ, Ye W, et al. Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease: interim results of a prospective observational case-controlled study. J Pediatr. 2020;219:62-69.e4.
Karnsakul W, Wasuwanich P, Ingviya T, et al. A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease. J Cyst Fibros. 2020;19(4):546-552.
Calvopina DA, Noble C, Weis A, et al. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis. J Cyst Fibros. 2020;19(3):449-454.
Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10(suppl 2):S29-S36.